Hepatocellular carcinoma in nonalcoholic fatty liver disease: A growing challenge

doi:10.4254/wjh.v13.i9.1107

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 9

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4456)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

296

WORD

167

HTML

2586

Figures (1-2)

200

Tables (1-2)

178

Sum=3427

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

419

Download

610

Sum=1029

Sep 27, 2021 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Hepatol. Sep 27, 2021; 13(9): 1107-1121
Published online Sep 27, 2021. doi: 10.4254/wjh.v13.i9.1107

Full Size Figure Download Figure

Figure 2 Main immune mechanisms of nonalcoholic fatty liver disease-related hepatocarcinogenesis. NAFLD: Nonalcoholic fatty liver disease; PD-L1: Programmed cell death ligand-1.

Citation: Mattos ÂZ, Debes JD, Dhanasekaran R, Benhammou JN, Arrese M, Patrício ALV, Zilio AC, Mattos AA. Hepatocellular carcinoma in nonalcoholic fatty liver disease: A growing challenge. World J Hepatol 2021; 13(9): 1107-1121
URL: https://www.wjgnet.com/1948-5182/full/v13/i9/1107.htm
DOI: https://dx.doi.org/10.4254/wjh.v13.i9.1107